Download | < Back |
16 May 2017 | |
Sub:- Glenmark Pharmaceuticals to Initiate Clinical Study for GBR 1342, Second Investigational New Drug from Immuno-Oncology Portfolio With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. | |
View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |